Joanne Xiu

6.5k total citations · 2 hit papers
257 papers, 3.8k citations indexed

About

Joanne Xiu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joanne Xiu has authored 257 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Oncology, 95 papers in Pulmonary and Respiratory Medicine and 95 papers in Cancer Research. Recurrent topics in Joanne Xiu's work include Cancer Genomics and Diagnostics (82 papers), Genetic factors in colorectal cancer (49 papers) and Colorectal Cancer Treatments and Studies (37 papers). Joanne Xiu is often cited by papers focused on Cancer Genomics and Diagnostics (82 papers), Genetic factors in colorectal cancer (49 papers) and Colorectal Cancer Treatments and Studies (37 papers). Joanne Xiu collaborates with scholars based in United States, Austria and Japan. Joanne Xiu's co-authors include Zoran Gatalica, Jeffrey Swensen, Semir Vranić, John L. Marshall, Anthony F. Shields, W. Michael Korn, Mohamed E. Salem, David Spetzler, Amy B. Heimberger and Jimmy J. Hwang and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Joanne Xiu

231 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular characterization of cancers with NTRK gene fusions

2018 345 citations Zoran Gatalica, Joanne Xiu et al. profile →
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

2017 308 citations Joanne Xiu, Zoran Gatalica et al. profile →

Peers

Countries citing papers authored by Joanne Xiu

Since Specialization

Citations

This map shows the geographic impact of Joanne Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Xiu more than expected).

Fields of papers citing papers by Joanne Xiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Xiu. The network helps show where Joanne Xiu may publish in the future.

Co-authorship network of co-authors of Joanne Xiu

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Xiu. A scholar is included among the top collaborators of Joanne Xiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Xiu. Joanne Xiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of O6‐Methylguanine‐DNA Methyltransferase Protein Expression by Immunohistochemistry Is Associated With Response to Capecitabine and Temozolomide in Neuroendocrine Neoplasms 2025 ·World Journal of Surgery ·Mark G. Evans, Joanne Xiu, Sourat Darabi, (unknown), (unknown), (unknown), Matthew J. Oberley, Michael J. Demeure	1
2	Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial 2024 ·European Urology ·Elizabeth R. Plimack, Catherine M. Tangen, Melissa Plets, (unknown), Joanne Xiu, Chadi Nabhan, Eric A. Ross, (unknown), Woonyoung Choi, (unknown), (unknown), (unknown), M. Scott Lucia, Siamak Daneshmand, Dan Theodorescu, Amir Goldkorn, Seth P. Lerner, Thomas W. Flaig, David J. McConkey	7
3	VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma 2024 ·Cancers ·(unknown), (unknown), Phillip M. Galbo, (unknown), Joanne Xiu, (unknown), (unknown), (unknown), (unknown), Soma Sengupta, (unknown), Charles G. Eberhart, David M. Loeb, Emad N. Eskandar, Deyou Zheng, Xingxing Zang, Allison Martin	4
4	75MO Atlas of tertiary lymphoid structures in solid tumors: Genomic features and prediction of response to immunotherapy 2024 ·Annals of Oncology ·Antoine Italiano, Jonathan C. Trent, George W. Sledge, Joanne Xiu, Emmanuel S. Antonarakis, Gina Z. D’Amato, David Hsieh, Andrew Elliott	1
5	Uncovering actionable genetic alterations and immune predictive biomarkers for anal squamous cell carcinomas in the era of immunotherapy: PD-L1 and beyond. 2024 ·Journal of Clinical Oncology ·(unknown), Yasmine Baca, Joanne Xiu, Alex Farrell, George W. Sledge, Anwaar Saeed, Anthony F. Shields, (unknown), Sanjay Goel, Benjamin A. Weinberg, Emil Lou	1
6	Clinical and molecular characterization of AXL in colorectal cancer: CALGB (Alliance)/SWOG 80405 and real-world data. 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), Joshua Millstein, Joanne Xiu, Shivani Soni, (unknown), (unknown), (unknown), Jae Ho Lo, (unknown), Priya Jayachandran, Wu Zhang, Anthony F. Shields, Richard M. Goldberg, Emil Lou, Benjamin A. Weinberg, John L. Marshall, Aaron S. Meyer, Francesca Battaglin, Heinz‐Josef Lenz	1
7	Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers 2024 ·Nature Cancer ·(unknown), Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik S. El‐Deiry, Emmanuel S. Antonarakis, Stephanie L. Graff, Michael J. Hall, Hossein Borghaei, Dave S.�B. Hoon, Stephen V. Liu, C. Patrick, Rana R. McKay, Trisha M. Wise‐Draper, John L. Marshall, George W. Sledge, David Spetzler, Hao Zhu, David Hsiehchen	11
8	Genomic and tumor microenvironment dynamics of brain metastases in breast cancer. 2024 ·Journal of Clinical Oncology ·(unknown), Sharon Wu, Sachin Kumar Deshmukh, Joanne Xiu, (unknown), (unknown), (unknown), Sarah Sammons, George W. Sledge, Stephanie L. Graff	0
9	Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II 2024 ·Clinical Cancer Research ·Glenn J. Hanna, Punita Grover, Andrew Elliott, (unknown), Joanne Xiu, Ammar Sukari, Jennifer M. Johnson, Trisha M. Wise‐Draper	6
10	Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target 2023 ·Medical Oncology ·Sourat Darabi, Joanne Xiu, (unknown), Santosh Kesari, Jose Carrillo, (unknown), Kyle M. Walsh, Soma Sengupta, Ashley Sumrall, David Spetzler, Michael Glantz, Michael J. Demeure	10
11	Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset 2023 ·Translational Oncology ·Misako Nagasaka, (unknown), Yasmine Baca, Joanne Xiu, Mohammed Najeeb Al Hallak, Chul Kim, Jorge J. Nieva, Jeffrey Swensen, David Spetzler, W. Michael Korn, Mark A. Socinski, Luis E. Raez, Balázs Halmos, Sai‐Hong Ignatius Ou	13
12	TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors 2021 ·Clinical Genitourinary Cancer ·Božo Krušlin, Zoran Gatalica, Ondřej Hes, Faruk Skenderi, Markku Miettinen, (unknown), Joanne Xiu, (unknown), (unknown), Semir Vranić, Jeffrey Swensen	14
13	Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes 2021 ·Cancers ·Hira Shaikh, (unknown), Brittany N. Hughes, Joanne Xiu, Pavel Brodskiy, Ammar Sukari, Sourat Darabi, Chukwuemeka Ikpeazu, Chadi Nabhan, W. Michael Korn, Trisha M. Wise‐Draper	16
14	Molecular Characterization of Appendiceal Goblet Cell Carcinoid 2020 ·Molecular Cancer Therapeutics ·Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, Natsuko Kawanishi, Jingyuan Wang, Shivani Soni, Wu Zhang, Joshua Millstein, Curtis Johnston, Richard M. Goldberg, Philip A. Philip, Andreas Seeber, Joanne Xiu, Jimmy J. Hwang, Anthony F. Shields, John L. Marshall, W. Michael Korn, Heinz‐Josef Lenz	18
15	Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer 2020 ·Clinical Cancer Research ·Jim Abraham, Daniel Magee, Chiara Cremolini, Carlotta Antoniotti, (unknown), Joanne Xiu, Phillip Stafford, Donald A. Berry, Matthew J. Oberley, Anthony F. Shields, John L. Marshall, Mohamed E. Salem, Alfredo Falcone, Axel Grothey, Michael J. Hall, Alan P. Venook, Heinz‐Josef Lenz, (unknown), W. Michael Korn, David Spetzler	35
16	The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer 2020 ·Molecular Cancer Therapeutics ·(unknown), Yasmine Baca, Joanne Xiu, Fábio Távora, Ira Winer, Benjamin A. Weinberg, Ari M. Vanderwalde, Sourat Darabi, W. Michael Korn, Andrew P. Mazar, Francis J. Giles, Lorin Crawford, Howard Safran, Wafik S. El‐Deiry, Benedito A. Carneiro	12
17	Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers 2020 ·Clinical Breast Cancer ·Semir Vranić, Phillip Stafford, Juan Palazzo, Faruk Skenderi, Jeffrey Swensen, Joanne Xiu, David Spetzler, Zoran Gatalica	28
18	Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma 2020 ·Journal of Surgical Oncology ·Matthew K. Stein, (unknown), Joanne Xiu, (unknown), Michael G. Martin, (unknown), Paxton V. Dickson, Evan S. Glazer, Danny Yakoub, David Shibata, Axel Grothey, Philip A. Philip, Jimmy J. Hwang, Anthony F. Shields, John L. Marshall, W. Michael Korn, Heinz‐Josef Lenz, Jeremiah L. Deneve	18
19	Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer 2019 ·Clinical Cancer Research ·Ryuma Tokunaga, Joanne Xiu, Curtis Johnston, Richard M. Goldberg, Philip A. Philip, Andreas Seeber, Madiha Naseem, Jae Ho Lo, Hiroyuki Arai, Francesca Battaglin, Alberto Puccini, Martin D. Berger, Shivani Soni, Wu Zhang, Jimmy J. Hwang, Anthony F. Shields, John L. Marshall, Hideo Baba, W. Michael Korn, Heinz‐Josef Lenz	62
20	Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers 2018 ·Molecular Cancer Research ·Mohamed E. Salem, Alberto Puccini, Axel Grothey, Derek Raghavan, Richard M. Goldberg, Joanne Xiu, W. Michael Korn, Benjamin A. Weinberg, Jimmy J. Hwang, Anthony F. Shields, John L. Marshall, Philip A. Philip, Heinz‐Josef Lenz	159

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact